Survival and Prognostic Factors for AIDS and Non-AIDS Patients with Non-Hodgkin’s Lymphoma in Bahia, Brazil: A Retrospective Cohort Study

Table 3

Predictive factors for EFS for patients with NHL, according to HIV serostatus.

Factors	HIV positive			HIV negative
	𝑁	Mean; (months)	IC	𝑁	Mean; (months)	IC	𝑃 value
ECOG
0-1	11	57	24.4–88.7	50	75	60.5–89.8	0.312
2-3	8	4	2.0–6.0	6	28	1.9–54.5	0.084
IPI
0-1	3	80	22.4–137.6	27	93	75.4–110.2	0.952
2-3	16	25	4.6–45.2	29	50	31.9–68.3	0.024
Bulky disease
Yes	8	10	2.5–17.5	20	52	28.8–75.5	0.007
No	19	51	27.3–74.6	41	78	62.0–93.0	0.082
LDH
Normal	5	74	28.5–119.1	23	85	65.7–104.2	0.958
Elevated	18	19	3.0–34.0	33	62	43.3–81.0	<0.001
Bone marrow infiltration
Yes	5	4	0.8–7.2	9	33	14.5–57.8	0.002
No	18	52	27.6–76.6	42	83	67.4–98.8	0.102
Disease stage
1-2	6	69	29.0–108.6	27	96	79.4–113.0	0.413
3-4	21	29	11.2–46.6	34	49	31.8–66.1	0.092
Absolute lymphocyte count (>1,000/mm³)
Yes	16	49	22.5–75.2	40	72	55.4–88.4	0.134
No	6	6	2.4–8.6	17	53	28.2–78.4	0.012
B symptoms
Yes	24	32	13.9–49.6	42	62	45.6–78.7	0.012
No	4	70	21.1–117.9	19	88	66.6–109.0	0.708